Clinical outcomes following ibrutinib and idelalisib-based therapy in CLL: A retrospective analysis

Type of Cancer
Lymphoma

Phase

Division (Location)

Study ID

NCT#

Brief Description
Clinical outcomes following ibrutinib and idelalisib-based therapy in CLL: A retrospective analysis

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.